Hayek Kallen Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,235
Closed -$229K 98
2026
Q1
$229K Buy
+6,235
New +$295K 0.07% 85
2025
Q4
Sell
-28,008
Closed -$1.55M 149
2025
Q3
$1.55M Sell
28,008
-20,151
-42% -$1.18M 0.49% 44
2025
Q2
$3.32M Sell
48,159
-2,837
-6% -$193K 1.13% 28
2025
Q1
$3.54M Sell
50,996
-4,224
-8% -$349K 1.3% 27
2024
Q4
$4.75M Sell
55,220
-1,340
-2% -$145K 1.73% 15
2024
Q3
$6.74M Sell
56,560
-1,350
-2% -$180K 2.39% 9
2024
Q2
$8.27M Sell
57,910
-725
-1% -$96.1K 3.08% 8
2024
Q1
$7.53M Sell
58,635
-1,863
-3% -$222K 2.89% 7
2023
Q4
$6.26M Sell
60,498
-4,763
-7% -$471K 2.61% 7
2023
Q3
$5.93M Sell
65,261
-1,435
-2% -$126K 2.66% 7
2023
Q2
$5.4M Buy
66,696
+480
+0.7% +$39.2K 2.3% 11
2023
Q1
$5.27M Sell
66,216
-3,636
-5% -$258K 2.38% 11
2022
Q4
$4.73M Sell
69,852
-1,200
-2% -$70.4K 2.18% 14
2022
Q3
$3.54M Sell
71,052
-350
-0.5% -$18.8K 1.66% 20
2022
Q2
$3.98M Sell
71,402
-1,250
-2% -$69.4K 1.73% 21
2022
Q1
$4.03M Sell
72,652
-1,450
-2% -$74.4K 1.49% 25
2021
Q4
$4.15M Sell
74,102
-1,950
-3% -$106K 1.48% 27
2021
Q3
$3.65M Sell
76,052
-3,538
-4% -$171K 1.67% 23
2021
Q2
$3.33M Sell
79,590
-396
-0.5% -$15.3K 1.4% 28
2021
Q1
$2.7M Hold
79,986
1.21% 30
2020
Q4
$2.79M Hold
79,986
1.35% 29
2020
Q3
$2.78M Sell
79,986
-730
-0.9% -$24.3K 1.55% 24
2020
Q2
$2.64M Sell
80,716
-748
-0.9% -$23.9K 1.5% 25
2020
Q1
$2.45M Sell
81,464
-1,630
-2% -$48.5K 1.64% 24
2019
Q4
$2.4M Sell
83,094
-120
-0.1% -$3.32K 1.39% 29
2019
Q3
$2.15M Sell
83,214
-846
-1% -$21.4K 1.34% 29
2019
Q2
$2.15M Sell
84,060
-454
-0.5% -$11.2K 1.36% 30
2019
Q1
$2.21M Sell
84,514
-640
-0.8% -$15.7K 1.43% 30
2018
Q4
$1.96M Buy
85,154
+124
+0.1% +$2.75K 1.41% 30
2018
Q3
$2M Buy
85,030
+430
+0.5% +$10.5K 1.28% 31
2018
Q2
$1.95M Sell
84,600
-2,094
-2% -$49.8K 1.35% 31
2018
Q1
$2.13M Sell
86,694
-3,050
-3% -$80.1K 1.48% 30
2017
Q4
$2.41M Sell
89,744
-1,000
-1% -$25.4K 1.58% 29
2017
Q3
$2.19M Sell
90,744
-27,896
-24% -$630K 1.5% 30
2017
Q2
$2.54M Sell
118,640
-440
-0.4% -$8.88K 1.72% 28
2017
Q1
$2.04M Buy
119,080
+1,150
+1% +$20K 1.41% 32
2016
Q4
$2.11M Sell
117,930
-600
-0.5% -$10.9K 1.54% 30
2016
Q3
$2.46M Buy
118,530
+6,700
+6% +$166K 1.76% 29
2016
Q2
$3.01M Sell
111,830
-1,100
-1% -$30.2K 2.16% 24
2016
Q1
$3.06M Sell
112,930
-1,350
-1% -$36.2K 2.27% 23
2015
Q4
$3.32M Sell
114,280
-800
-0.7% -$22.1K 2.54% 19
2015
Q3
$3.12M Sell
115,080
-2,600
-2% -$73.6K 2.43% 19
2015
Q2
$3.22M Buy
117,680
+200
+0.2% +$5.62K 2.41% 20
2015
Q1
$3.14M Buy
117,480
+5,000
+4% +$115K 2.31% 20
2014
Q4
$2.38M Sell
112,480
-1,200
-1% -$26.8K 1.76% 25
2014
Q3
$2.71M Sell
113,680
-900
-0.8% -$20.7K 2.06% 22
2014
Q2
$2.65M Sell
114,580
-666
-0.6% -$14.7K 2% 22
2014
Q1
$2.63M Sell
115,246
-174
-0.2% -$3.71K 2.1% 22
2013
Q4
$2.13M Sell
115,420
-1,500
-1% -$26.1K 1.66% 26
2013
Q3
$1.98M Sell
116,920
-50
-0% -$841 1.63% 25
2013
Q2
$1.81M Buy
+116,970
New +$1.95M 1.53% 26

Other funds holding NVO

Hayek Kallen Investment Management's NVO Position: Q2 2026 in Review

Hayek Kallen Investment Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,235 shares — an estimated $229K sold.

Hayek Kallen Investment Management first reported a position in NVO in Q2 2013 and held it in 51 quarters. The position peaked at $8.27M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hayek Kallen Investment Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Hayek Kallen Investment Management sold 6,235 Novo Nordisk shares in Q2 2026, an estimated $229K.
  • Hayek Kallen Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 51 quarters.
  • Hayek Kallen Investment Management's Novo Nordisk position peaked at $8.27M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hayek Kallen Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.